Regulation
Are peptides legal? It depends where you are standing.
Are peptides legal in the United States?
Approved peptides — semaglutide, tirzepatide, tesamorelin, bremelanotide — are prescription drugs. Most others are not approved for anything.
European UnionAre peptides legal in the EU?
Semaglutide, tirzepatide and liraglutide are authorised, prescription-only medicines across the EU. Almost every other peptide discussed online has no marketing authorisation, so supplying it for human use is an offence under the medicines laws of every member state.
United KingdomAre peptides legal in the UK?
Licensed peptides — semaglutide, tirzepatide, liraglutide — are prescription-only medicines. Everything else on LYO is an unlicensed medicine under the Human Medicines Regulations 2012: selling or supplying it is a criminal offence, and the MHRA is prosecuting.
AustraliaAre peptides legal in Australia?
In Australia peptides are prescription-only substances. Registered ones (semaglutide, tirzepatide) are Schedule 4 medicines; unapproved ones (BPC-157, TB-500, CJC-1295, ipamorelin and the rest) are also Schedule 4 but not on the Register, so they can only be obtained on a prescription, compounded for that patient, or imported under the Personal Importation Scheme with a prescription.
CanadaAre peptides legal in Canada?
Semaglutide, tirzepatide and tesamorelin are authorised prescription drugs in Canada. The research-market peptides are not authorised at all — Health Canada has not assessed them for safety, efficacy or quality — and "selling unauthorized drugs is illegal in Canada".
Sport (WADA)Which peptides are banned in sport?
Under the 2026 Prohibited List, nearly every peptide discussed online is banned at all times, in and out of competition: growth-hormone releasing factors and secretagogues (sermorelin, CJC-1295, ipamorelin, tesamorelin, GHRPs), growth-hormone fragments (AOD-9604), thymosin-β4 (TB-500), MOTS-c, kisspeptin, and — under S0 — anything not approved for human use anywhere, which covers BPC-157, epitalon, retatrutide and cagrilintide. Semaglutide and tirzepatide are not on the list..
Matrix
Every compound, every jurisdiction
Status at a glance. Open a compound for the notes and sources behind each cell; open a region for the rules that produce them.
| Compound | United States | European Union | United Kingdom | Australia | Canada | Sport (WADA) |
|---|---|---|---|---|---|---|
| D BPC-157 | Not approved; compounding under review | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| A Semaglutide | Approved, prescription-only | Approved, prescription-only | Licensed, prescription-only | Registered, Schedule 4 | Authorised, prescription-only | Not prohibited |
| B Retatrutide | Investigational; cannot be compounded | Investigational; not authorised | Unlicensed; illegal to sell | Unapproved | Not authorised | Prohibited at all times |
| A Tirzepatide | Approved, prescription-only | Approved, prescription-only | Licensed, prescription-only | Registered, Schedule 4 | Authorised, prescription-only | Not prohibited |
| B Tesamorelin | Approved (Egrifta), prescription-only | Not authorised | Not licensed | Not registered | Authorised (Egrifta), prescription-only | Prohibited at all times |
| C Ipamorelin | Not approved; compounding barred | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| C GHK-Cu | Cosmetic; injectable not approved | Cosmetic ingredient; no medicinal authorisation | Cosmetic; injectable unlicensed | Cosmetic; injectable unapproved | Cosmetic; injectable not authorised | Not named |
| D Epitalon | Not approved; compounding under review | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| D TB-500 | Not approved; compounding under review | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| B Cagrilintide | Investigational; cannot be compounded | Investigational; not authorised | Unlicensed | Unapproved | Not authorised | Prohibited at all times |
| D Semax | Not approved; compounding under review | Unauthorised in the EU | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Not on the list |
| D Selank | Not approved | Unauthorised in the EU | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Not on the list |
| A PT-141 | Approved (Vyleesi), prescription-only | Not authorised | Not licensed | Not registered | Not authorised | Not on the list |
| C Sermorelin | Discontinued brand; compounded on prescription | No current authorisation | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| C CJC-1295 | Not approved; compounding barred | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| D AOD-9604 | Not approved; compounding barred | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
| D MOTS-c | Not approved; compounding under review | Unauthorised medicinal product | Unlicensed medicine | Schedule 4, unapproved | Not authorised | Prohibited at all times |
Last checked against the regulators' own pages on 2 September 2026. Legal status changes; LYO records every change on the region pages. This is a reference, not legal advice.